Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Melanoma 19Colorectal Neoplasms 11Brain Neoplasms 7Colonic Neoplasms 5Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Rectal Neoplasms 2Lung Neoplasms 2Thyroid Neoplasms 1Solid Tumor 1Skin Neoplasms 1Recurrence 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphatic Metastasis 1Leukemia, Hairy Cell 1Hematologic Neoplasms 1Gliosarcoma 1Glioma 1Glioblastoma 1Astrocytoma 1

Interventions

Radiotherapy, Intensity-Modulated 3Cisplatin 2encorafenib 1binimetinib 1alovudine 1X-Rays 1Specimen Handling 1Radiotherapy 1Radiosurgery 1Radiation Dose Hypofractionation 1Platinum 1Nivolumab 1Metastasectomy 1Magnetic Resonance Spectroscopy 1Leuprolide 1Ipilimumab 1Goserelin 1Drug Therapy 1Docetaxel 1Axitinib 1Androgen Antagonists 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Lymphatic Metastasis × encorafenib × Clear all
NCT04221438 2026-05-12

Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement

Eastern Cooperative Oncology Group

Phase 2 Terminated
3 enrolled 11 charts
Dermatologic

Lymphatic Metastasis, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡